Re: α-Lipoic Acid Treatment Prevents Cystine Urolithiasis in a Mouse Model of Cystinuria.
作者信息
Assimos Dean G
出版信息
J Urol. 2017 Nov;198(5):975. doi: 10.1016/j.juro.2017.08.029. Epub 2017 Aug 9.
PMID:29059768
Abstract
摘要
相似文献
1
Re: α-Lipoic Acid Treatment Prevents Cystine Urolithiasis in a Mouse Model of Cystinuria.
J Urol. 2017 Nov;198(5):975. doi: 10.1016/j.juro.2017.08.029. Epub 2017 Aug 9.
2
α-Lipoic acid treatment prevents cystine urolithiasis in a mouse model of cystinuria.α-硫辛酸治疗可预防胱氨酸尿症小鼠模型中的胱氨酸尿路结石。
Nat Med. 2017 Mar;23(3):288-290. doi: 10.1038/nm.4280. Epub 2017 Feb 6.
3
Stones: Cystinuria - supplement supports solubilization.结石：胱氨酸尿症 - 补充剂有助于溶解。
Nat Rev Urol. 2017 Jun;14(6):324. doi: 10.1038/nrurol.2017.27. Epub 2017 Feb 21.
4
Slc7a9-deficient mice develop cystinuria non-I and cystine urolithiasis.Slc7a9基因缺陷小鼠会出现非I型胱氨酸尿症和胱氨酸尿路结石。
Hum Mol Genet. 2003 Sep 1;12(17):2097-108. doi: 10.1093/hmg/ddg228. Epub 2003 Jul 15.
5
α-Lipoic Acid (ALA) Improves Cystine Solubility in Cystinuria: Report of 2 Cases.α-硫辛酸（ALA）可提高胱氨酸尿症患者胱氨酸的溶解度：2 例报告。
Pediatrics. 2020 May;145(5). doi: 10.1542/peds.2019-2951. Epub 2020 Apr 3.
6
Tolvaptan treatment of cystine urolithiasis in a mouse model of cystinuria.托伐普坦治疗胱氨酸尿症模型小鼠胱氨酸结石。
World J Urol. 2021 Jan;39(1):263-269. doi: 10.1007/s00345-020-03166-3. Epub 2020 Mar 18.
7
[Cystinuria and cystine urolithiasis].[胱氨酸尿症与胱氨酸尿路结石]
Klin Med (Mosk). 1972 Feb;50(2):129-35.
8
Novel cystine ester mimics for the treatment of cystinuria-induced urolithiasis in a knockout mouse model.用于治疗基因敲除小鼠模型中胱氨酸尿症诱发的尿路结石的新型胱氨酸酯模拟物。
Urology. 2014 Nov;84(5):1249.e9-15. doi: 10.1016/j.urology.2014.07.043. Epub 2014 Oct 24.
9
[Beneficial effect of angiotensin converting enzyme inhibitor treatment in severe cystine urolithiasis].[血管紧张素转换酶抑制剂治疗重度胱氨酸尿石症的有益作用]
Pol Merkur Lekarski. 2003 Mar;14(81):253-5.
10
[Cystinuria and cystine urolithiasis in 40 children].[40例儿童胱氨酸尿症和胱氨酸尿路结石]
Cesk Pediatr. 1972 May;27(5):228-9.
Zotero 插件